Rankings
▼
Calendar
VSTM Q3 2020 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$79M
+770.8% YoY
Gross Profit
$47M
59.2% margin
Operating Income
$15M
19.1% margin
Net Income
$13M
16.7% margin
EPS (Diluted)
$0.96
QoQ Revenue Growth
+1726.0%
Cash Flow
Operating Cash Flow
$43M
Free Cash Flow
$43M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$218M
Total Liabilities
$88M
Stockholders' Equity
$130M
Cash & Equivalents
$170M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$79M
$9M
+770.8%
Gross Profit
$47M
$8M
+463.4%
Operating Income
$15M
-$26M
+157.5%
Net Income
$13M
-$30M
+143.6%
Revenue Segments
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$320,000
36%
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$296,000
33%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$147,000
17%
Product Revenue And Allowances Returns
$126,000
14%
← FY 2020
All Quarters
Q4 2020 →